Brief: Private Equity Holding's portfolio Company Enanta gets U.S. FDA Approval for AbbVie's VIEKIRA PAK
22/12/2014 06:02
Dec 22 (Reuters) - Private Equity Holding AG PEHN.S :
* Private Equity Holding: portfolio company Enanta announces
U.S. FDA approval for AbbVie's VIEKIRA PAK
* Says Enanta has announced that U.S. FDA has approved
AbbVie's VIEKIRA PAK for treatment of Chronic Genotype 1
Hepatitis C Virus
Source text for Eikon: ID:nHUGbDTMvR
Further company coverage: PEHN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Keywords: PRIVATEEQUITY/BRIEF
Recent news on Private Equity Holding AG
See all newsBrief: Private Equity Holding Says Net Asset Value Per Share Of Co EUR 165.06, As Of November 30, 2024
Brief: Private Equity Holding AG Says As Of July 31, 2024, Net Asset Value Per Share Stood At EUR 160.00 (CHF 152.38)
Brief: Private Equity Holding Says Shareholders Of Private Equity Holding AG Approve All Proposals By The Board
Brief: Private Equity Holding Says Board Of Directors Will Propose A Dividend Of CHF 1 Per Share
Brief: Private Equity Holding Says Net Asset Value Was AT EUR 153.60 As Of Jan 31